Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Zenith DrugsNSE:ZENITHDRUG +1.80%36 Days Inventory is 108.38 as of Mar. 2026, which is 25% above its 10-year median of 86.67. GuruFocus rates NSE:ZENITHDRUG with a GF Score™ of 36/100. The stock has 8 warning signs investors should review. Among 921 Drug Manufacturers companies, Zenith Drugs ranks better than 70.9% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). Zenith Drugs's Average Total Inventories for the
six
months ended in Mar. 2026 was ₹405 Mil. Zenith Drugs's Cost of Goods Sold for the
six
months ended in Mar. 2026 was ₹681 Mil.
Hence, Zenith Drugs's Days Inventory for the
six
months ended in Mar. 2026 was 108.38.
The historical rank and industry rank for Zenith Drugs's Days Inventory or its related term are showing as below:
NSE:ZENITHDRUG'
s Days Inventory Range Over the Past 10 Years
Min: 46.15 Med: 86.67 Max: 136.37
Current: 119.67
During the past 6 years, Zenith Drugs's highest Days Inventory was 136.37. The lowest was 46.15. And the median was 86.67.
NSE:ZENITHDRUG's Days Inventory is ranked better than 70.9% of 921
companies
in the Drug Manufacturers industry
Industry Median: 164.48
vs NSE:ZENITHDRUG: 119.67
Zenith Drugs's Days Inventory
declined
from Mar. 2025 (177.10) to Mar. 2026 (108.38).
Inventory Turnover measures how fast the company turns over its inventory within a year.
Zenith Drugs's Inventory Turnover for the
six
months ended in Mar. 2026 was 1.68.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zenith Drugs's Inventory-to-Revenue for the
six
months ended in Mar. 2026 was 0.44.
Zenith Drugs (NSE:ZENITHDRUG) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Zenith Drugs's Inventory Turnover for the
six
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Zenith Drugs's Inventory to Revenue for the
six
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Zenith Drugs Days Inventory Related Terms
Zenith Drugs Days Inventory Historical Data
* Premium members only.
The historical data trend for Zenith Drugs's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:ZENITHDRUG vs ZTS, UTHR: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Zenith Drugs's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Zenith Drugs Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Zenith Drugs's Days Inventory distribution charts can be found below:
* The bar in red indicates where Zenith Drugs's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Zenith Drugs (NSE:ZENITHDRUG) has a Days Inventory of 108.38 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zenith Drugs and its competitors. This is 25% above median its historical median of 86.67. Over the past decade, Zenith Drugs' Days Inventory has ranged from 46.15 to 136.37. According to the industry distribution chart, Zenith Drugs ranks #268 out of 921 companies in the Drug Manufacturers industry, placing it in the top 29.1%.
Is Zenith Drugs' Days Inventory too high?
Zenith Drugs' current Days Inventory of 108.38 is 25% above median its 10-year median of 86.67. Over the past 10 years, this metric has ranged from a low of 46.15 to a high of 136.37. The Drug Manufacturers industry median Days Inventory is 164.48. Zenith Drugs' value of 108.38 is 34.1% below this industry median. Based on the distribution chart, Zenith Drugs ranks #268 out of 921 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Zenith Drugs has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does Zenith Drugs' Days Inventory compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Zenith Drugs ranks #268 out of 921 companies for Days Inventory. This puts Zenith Drugs in the upper half of its industry. The industry median Days Inventory is 164.48. Zenith Drugs' value of 108.38 is 34.1% below this benchmark. Historically, Zenith Drugs' own Days Inventory has ranged from 46.15 to 136.37 over the past decade. While the company's 10-year median is 86.67 vs. the industry median of 164.48, Zenith Drugs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 164.48, based on 921 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Zenith Drugs's current Days Inventory of 108.38 is 34.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Zenith Drugs and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 164.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Zenith Drugs's current Days Inventory is 108.38, which is 25% above median its own 10-year median of 86.67. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Zenith Drugs stock overvalued right now?
Zenith Drugs (NSE:ZENITHDRUG) has a current Days Inventory of 108.38. The current Days Inventory is 108.38, which is 25% above median its 10-year median of 86.67 and 34.1% below the Drug Manufacturers industry median of 164.48. Zenith Drugs' overall GF Score™ is 36/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Zenith Drugs (NSE:ZENITHDRUG), the current Days Inventory is 108.38 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, Creams, Gels, Capsules, and Tablets. It is also into Generic Medicines.
36GF Score
Get the complete analysis for NSE:ZENITHDRUG
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ZENITHDRUG has been successfully added to your 
